This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 19-22, 2025
Manchester Grand Hyatt San DiegoSan Diego, CA
Menu

Manmohan Singh, PhD
Chief Technology Officer at Beam Therapeutics
Speaker

Profile

Dr.Manmohan Singh is currently the Chief Technology Officer at Beam Therapeutics in Cambridge, MA. Dr. Singh has over 28 years of R&D experience in drug product development, novel delivery systems, genetic medicines and vaccine research. He previously led technical teams overseeing early and late stage development programs at Takeda and Novartis. His team was instrumental in approval of several novel vaccines (FluAd®,Bexsero®,Menveo®,Flucelvax®). Dr. Singh has authored over 130 peer reviewed papers and is the editor of 6 Books on vaccines and drug product development. He was elected as a Fellow of the American Association of Pharmaceutical Scientists (AAPS) in 2011.

Agenda Sessions

  • Panel Discussion: Addressing the Challenges of Bringing New Therapeutic Modalities to Market: Technical and Regulatory Considerations

    , 4:15pm
    View Session

  • Chairman’s Remarks: Genome Editing Delivery

    , 8:25am
    View Session

  • Innovations in Delivery Technologies to Advance Base Editing to the Clinic

    , 9:00am
    View Session

At this event

Prev
Next
Colin Smith
Innovation Leader, Pharma
Aurorium

See Manmohan at TIDES USA: Oligonucleotide & Peptide Therapeutics